Hydrolysis in pharmaceutical formulations.

Hydrolysis in pharmaceutical formulations.

Item
http://www.wikidata.org/entity/Q34687296
Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and DevelopmentPreparation of alginate beads containing a prodrug of diethylenetriaminepentaacetic acid.Estimation of sertraline by chromatographic (HPLC-UV273 nm) technique under hydrolytic stress conditions.Deliquescence of pharmaceutical systems.Overview of drug product development.Impact of excipient interactions on solid dosage form stability.More than just crushing: a prospective pre-post intervention study to reduce drug preparation errors in patients with feeding tubes.ChemStable: a web server for rule-embedded naïve Bayesian learning approach to predict compound stability.Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate.Measuring Biomolecular DSC Profiles with Thermolabile Ligands to Rapidly Characterize Folding and Binding Interactions.
P2860

Hydrolysis in pharmaceutical formulations.

Item
http://www.wikidata.org/entity/Q34687296
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hydrolysis in pharmaceutical formulations.
@ast
Hydrolysis in pharmaceutical formulations.
@en
Hydrolysis in pharmaceutical formulations.
@nl
type
label
Hydrolysis in pharmaceutical formulations.
@ast
Hydrolysis in pharmaceutical formulations.
@en
Hydrolysis in pharmaceutical formulations.
@nl
prefLabel
Hydrolysis in pharmaceutical formulations.
@ast
Hydrolysis in pharmaceutical formulations.
@en
Hydrolysis in pharmaceutical formulations.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Hydrolysis in pharmaceutical formulations.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698